Edward KliphuisPartner at Sofinnova Partners
Edward is part of the investment team at Sofinnova Partners where he joined as a Partner in June 2021. He came from M Ventures, Merck KGaA’s corporate VC arm, where he focused on investments in cutting-edge digital medicine companies and before that, was in the Life Sciences securities team at Kempen & Co.
Edward is positive, energetic and purpose driven. He holds an M.Sc. in Biopharmaceutical Sciences from Leiden University, the Netherlands, with a specialisation in pharmacology.